May 2024 | Report Format: Electronic (PDF)
Cell Signaling Market Growth & Trends
The global cell signaling market size is expected to reach USD 8.94 billion by 2030, according to a new report by Grand View Research, Inc. The market is estimated to register a CAGR of 7.56% from 2024 to 2030. A rising emphasis on stem cell research significantly contributes to the growth and development of the cell signaling industry. Stem cells provide a model system to study the intricate processes of cellular differentiation and development. Cell signaling pathways play a crucial role in directing stem cells toward specific cell differentiation, rendering cell signaling technology a dependable tool that significantly contributes to overall market expansion.
Furthermore, stem cells also play a pivotal role in drug discovery and disease modeling, with cell signaling research providing essential knowledge on the pathways modulated by therapeutic compounds and the dysregulations observed in various diseases. Rising government funding further boosts developments in stem cell research. For instance, in March 2020, Canada’s government allocated approximately USD 7 million towards regenerative medicine and stem cell research with an aim to support nine transnational projects and four clinical trials within the country, contributing to the expansion of the regenerative medicine sector. Therefore, as the demand for stem cells rises, it consequently propels market growth for cell signaling process.
Additionally, technological advancements such as rising omics technologies play a significant role in driving market growth. Omics technologies facilitate the identification of biomarkers associated with specific cell signaling events.These biomarkers serve as indicators of normal cellular function or aberrations linked to diseases, which plays a crucial role in early disease detection, prognosis, and monitoring treatment responses. Thus, the application of these technologies enhances the understanding of cell signaling pathways and contributes significantly to the growth of the cell signaling industry.
Request a free sample copy or view report summary:
Cell Signaling Market Report
Cell Signaling Market Report Highlights
- Based on type, endocrine signaling dominated the market with a revenue share of 42.9% in 2023. The increased prevalence of endocrine-related disorders such as adrenal insufficiency, Cushing’s disease, gigantism, hypothyroidism, as well as hyperthyroidism is one of the primary drivers driving market expansion
- In terms of product, consumables held the largest revenue share of 58.3% in 2023. This has been ascribed to the increasing need for cell signaling as a result of byproducts that include reagents, test kits, and antibodies. Expansion of the medical supplies industry is another factor driving segment demand
- On the basis of technology, microscopy dominates the market with a revenue share of 35.8% in 2023. The factors that can be linked to technological breakthroughs in recent years have accelerated the development of light microscopy, which is boosting demand for this segment
- Based on pathway, the AKT signaling pathway segment held a dominant share of 43.1% in 2023. The predicted development of commercial diagnostic tests based on AKT pathway downregulation will drive the cell signaling sector to flourish over the forecast timeframe
- North America dominated the global industry in 2023 with a revenue share of 40.3%, owing to the presence of key market players in this region. Majority of the key companies in this region’s cell signaling industry have been actively involved in R&D activities involving cell signaling pathways
Cell Signaling Market Segmentation
Grand View Research has segmented the global cell signaling market based on type, product, technology, pathway, and region:
Cell Signaling Type Outlook (Revenue, USD Million, 2018–2030)
- Endocrine Signaling
- Paracrine Signaling
- Autocrine Signaling
- Others
Cell Signaling Product Outlook (Revenue, USD Million, 2018–2030)
- Consumables
- Instruments
Cell Signaling Technology Outlook (Revenue, USD Million, 2018–2030)
- Flow Cytometry
- Microscopy
- Western Blotting
- ELISA
- Others
Cell Signaling Pathway Outlook (Revenue, USD Million, 2018–2030)
- AKT Signaling Pathway
- AMPK Signaling Pathway
- ErbB/HER Signaling Pathway
- Other Signaling Pathway
List of Key Companies in the Cell Signaling Market
- Thermo Fisher Scientific, Inc.
- QIAGEN
- Becton, Dickinson and Company
- Bio-Rad Laboratories Inc.
- Bio-Techne Corporation
- Cell Signaling Technology Inc.
- Danaher
- Merck KGaA
- PerkinElmer Inc.
- Promega Corporation
